Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Q32 Bio (QTTB) Non Operating Income (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Non Operating Income data on record, last reported at $11.9 million in Q4 2025.

  • For Q4 2025, Non Operating Income fell 27.06% year-over-year to $11.9 million; the TTM value through Dec 2025 reached $12.9 million, down 64.02%, while the annual FY2025 figure was $12.9 million, 35.45% down from the prior year.
  • Non Operating Income reached $11.9 million in Q4 2025 per QTTB's latest filing, up from $189000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $131.3 million in Q1 2022 and bottomed at -$7.1 million in Q3 2023.
  • Average Non Operating Income over 5 years is $8.9 million, with a median of $866000.0 recorded in 2023.
  • Peak YoY movement for Non Operating Income: skyrocketed 345376.32% in 2022, then plummeted 663.04% in 2023.
  • A 5-year view of Non Operating Income shows it stood at $42000.0 in 2021, then surged by 3364.29% to $1.5 million in 2022, then tumbled by 169.07% to -$1.0 million in 2023, then soared by 1716.72% to $16.2 million in 2024, then dropped by 27.06% to $11.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $11.9 million in Q4 2025, $189000.0 in Q3 2025, and -$318000.0 in Q2 2025.